Clinical Trials Browser

Phase 2 × Completed × sacituzumab govitecan × Clear all

NCT05226117 2026-03-27

Sacituzumab Govitecan, Preceding Radical Cystectomy, in Treating Patients With Muscle-invasive Bladder Cancer

Phase 2 Completed

Carcinoma, Transitional Cell

NCT05520723 2025-12-04

PRIMED

Phase 2 Completed

Breast Neoplasms, Triple Negative Breast Neoplasms